Antares Pharma Company Profile (NASDAQ:ATRS)

About Antares Pharma

Antares Pharma logoAntares Pharma, Inc. (Antares) is a specialty pharmaceutical Company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures for itself and with partners, pressure-assisted injectors, with and without needles, which allow patients to self-inject drugs. It has developed variations of the needle-free injector by adding a small shielded needle to a pre-filled, single-use disposable injector, called the Vibex pressure assisted auto injection system. This system is an alternative to the needle-free system for use with injectable drugs in unit dose containers and is suitable for branded and generic injectables. It has also developed a disposable multi-dose pen injector for use with standard cartridges.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ATRS
  • CUSIP: 03664210
Key Metrics:
  • Previous Close: $1.30
  • 50 Day Moving Average: $1.0592
  • 200 Day Moving Average: $0.9717
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -21.67
  • P/E Growth: -0.1000
  • Market Cap: $198.46M
  • Outstanding Shares: 155,058,000
  • Beta: 0.71
Additional Links:
Companies Related to Antares Pharma:

Analyst Ratings

Consensus Ratings for Antares Pharma (NASDAQ:ATRS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (130.77% upside)

Analysts' Ratings History for Antares Pharma (NASDAQ:ATRS)
Show:
DateFirmActionRatingPrice TargetDetails
8/13/2016Piper Jaffray Cos.Reiterated RatingOverweight$3.00 -> $2.00View Rating Details
5/10/2016Jefferies GroupReiterated RatingBuy$3.00View Rating Details
9/25/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$4.00View Rating Details
10/22/2014JMP SecuritiesInitiated CoverageOutperform$4.00View Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Antares Pharma (NASDAQ:ATRS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/9/2016Q216($0.04)($0.04)$11.00 million$12.20 millionViewN/AView Earnings Details
5/9/2016Q1($0.03)($0.05)$11.10 million$12.30 millionViewN/AView Earnings Details
3/8/2016Q415($0.03)($0.04)$12.53 million$11.80 millionViewN/AView Earnings Details
11/5/2015Q3 15($0.03)($0.04)ViewN/AView Earnings Details
8/10/2015Q215($0.03)($0.01)$10.93 million$14.40 millionViewListenView Earnings Details
5/11/2015Q115($0.04)($0.05)$9.22 million$8.30 millionViewListenView Earnings Details
3/12/2015Q414($0.05)($0.08)$8.50 million$8.40 millionViewN/AView Earnings Details
11/6/2014($0.07)($0.05)ViewN/AView Earnings Details
8/7/2014Q214($0.07)($0.07)$6.43 million$6.30 millionViewN/AView Earnings Details
5/9/2014Q114($0.05)($0.07)$6.17 million$5.20 millionViewN/AView Earnings Details
3/13/2014Q413($0.05)($0.04)$6.20 million$4.70 millionViewN/AView Earnings Details
11/6/2013Q313($0.04)($0.05)$5.86 million$5.50 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.03)($0.04)$5.82 million$5.84 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.03)($0.03)$5.12 million$4.50 millionViewN/AView Earnings Details
3/13/2013Q4 2012($0.03)($0.04)$5.36 million$5.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.03)($0.03)$5.62 million$5.68 millionViewN/AView Earnings Details
8/8/2012($0.03)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Antares Pharma (NASDAQ:ATRS)
Current Year EPS Consensus Estimate: $-0.15 EPS
Next Year EPS Consensus Estimate: $-0.06 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.04)($0.04)($0.04)
Q2 20161($0.04)($0.04)($0.04)
Q3 20162($0.03)$0.02($0.01)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Antares Pharma (NASDAQ:ATRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Antares Pharma (NASDAQ:ATRS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2016Peter J GrahamSVPBuy20,000$0.77$15,400.00View SEC Filing  
3/18/2016James E FickenscherCFOBuy135,000$0.72$97,200.00View SEC Filing  
3/18/2016Leonard S JacobDirectorBuy50,000$0.72$36,000.00View SEC Filing  
3/18/2016Robert F AppleCEOBuy60,000$0.72$43,200.00View SEC Filing  
9/30/2015James E FlynnMajor ShareholderSell249,998$1.69$422,496.62View SEC Filing  
9/29/2015James E FlynnMajor ShareholderSell225,048$1.82$409,587.36View SEC Filing  
9/28/2015James E FlynnMajor ShareholderSell1,353,483$1.81$2,449,804.23View SEC Filing  
8/24/2015Robert P Roche JrDirectorBuy5,000$1.77$8,850.00View SEC Filing  
8/13/2015Robert P Roche JrDirectorBuy5,000$1.94$9,700.00View SEC Filing  
7/20/2015James E FlynnInsiderSell231,793$2.17$502,990.81View SEC Filing  
7/8/2015James E FlynnMajor ShareholderSell444,341$2.05$910,899.05View SEC Filing  
7/7/2015James E FlynnMajor ShareholderSell198,651$2.09$415,180.59View SEC Filing  
7/6/2015James E FlynnMajor ShareholderSell191,513$2.12$406,007.56View SEC Filing  
7/1/2015James E FlynnInsiderSell713,222$2.09$1,490,633.98View SEC Filing  
6/30/2015James E FlynnMajor ShareholderSell608,691$2.08$1,266,077.28View SEC Filing  
6/29/2015James E FlynnMajor ShareholderSell60,695$2.18$132,315.10View SEC Filing  
6/26/2015James E FlynnInsiderSell756,852$2.27$1,718,054.04View SEC Filing  
6/23/2015James E FlynnInsiderSell499,895$2.39$1,194,749.05View SEC Filing  
6/18/2015James E FlynnInsiderSell478,366$2.44$1,167,213.04View SEC Filing  
6/15/2015James E FlynnInsiderSell748,030$2.44$1,825,193.20View SEC Filing  
3/23/2015Leonard S JacobDirectorSell23,500$2.68$62,980.00View SEC Filing  
9/10/2014Eamonn P HobbsCEOBuy9,000$2.20$19,800.00View SEC Filing  
8/13/2014Robert P Roche JrDirectorBuy5,000$1.96$9,800.00View SEC Filing  
8/11/2014Marvin SamsonDirectorBuy25,000$2.00$50,000.00View SEC Filing  
12/9/2013Paul WottonCEOSell64,100$4.00$256,400.00View SEC Filing  
10/14/2013Robert AppleCFOSell22,000$5.05$111,100.00View SEC Filing  
9/3/2013Anton GuethDirectorSell25,000$4.42$110,500.00View SEC Filing  
9/3/2013Paul WottonCEOSell35,000$4.41$154,350.00View SEC Filing  
8/1/2013Anton GuethDirectorSell25,000$4.41$110,250.00View SEC Filing  
8/1/2013Paul K WottonCEOSell35,000$4.42$154,700.00View SEC Filing  
7/1/2013Anton GuethDirectorSell25,000$4.15$103,750.00View SEC Filing  
7/1/2013Paul K WottonCEOSell35,000$4.14$144,900.00View SEC Filing  
6/25/2013Eamonn P HobbsDirectorSell23,500$4.19$98,465.00View SEC Filing  
6/4/2013Robert F AppleCFOSell115,000$4.02$462,300.00View SEC Filing  
6/3/2013Anton GuethDirectorSell25,000$4.01$100,250.00View SEC Filing  
6/3/2013Kaushik J DaveEVPSell48,000$4.01$192,480.00View SEC Filing  
6/3/2013Paul K WottonCEOSell125,000$4.01$501,250.00View SEC Filing  
5/31/2013Thomas J GarrityDirectorSell13,000$4.08$53,040.00View SEC Filing  
5/17/2013Leonard S JacobDirectorSell17,000$4.00$68,000.00View SEC Filing  
11/16/2012Leonard S JacobDirectorBuy10,000$3.44$34,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Antares Pharma (NASDAQ:ATRS)
DateHeadline
News IconMagnifying Stocks of Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 23 at 3:42 PM
News IconShares Going Higher in Session: Antares Pharma Inc. (NASDAQ:ATRS) - Post News (NASDAQ:ATRS)
www.kentuckypostnews.com - August 23 at 3:42 PM
News IconLet's Take a Closer Look at Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 22 at 8:44 PM
investornewswire.com logoWill Antares Pharma, Inc. (NASDAQ:ATRS) Hit $3 Price Target? - Investor Newswire (NASDAQ:ATRS)
www.investornewswire.com - August 21 at 8:22 AM
News IconSmall Cap Insight on Shares of Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 20 at 3:39 PM
finance.yahoo.com logoANTARES PHARMA, INC. Financials (NASDAQ:ATRS)
finance.yahoo.com - August 19 at 4:17 PM
zacks.com logoLabCorp Q2 Results Strong, Sequenom Buyout Raises Hope (NASDAQ:ATRS)
www.zacks.com - August 19 at 12:01 PM
News IconTaking A Closer Look at Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 17 at 3:42 PM
News IconA Closer Look at Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 16 at 3:43 PM
News IconShares Moving Up to a Recent High: Antares Pharma Inc. (NASDAQ:ATRS) - Post News (NASDAQ:ATRS)
www.kentuckypostnews.com - August 16 at 3:43 PM
capitalcube.com logoETF’s with exposure to Antares Pharma, Inc. : August 16, 2016 (NASDAQ:ATRS)
www.capitalcube.com - August 16 at 12:16 PM
News IconSmall Cap Update on: Antares Pharma Inc. (NASDAQ:ATRS) - Duncan Research (NASDAQ:ATRS)
www.duncanindependent.com - August 15 at 3:42 PM
capitalcube.com logoAntares Pharma, Inc. :ATRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:ATRS)
www.capitalcube.com - August 15 at 3:42 PM
capitalcube.com logoAntares Pharma, Inc. :ATRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:ATRS)
www.capitalcube.com - August 15 at 3:42 PM
streetinsider.com logoAntares Pharma's (ATRS) CFO Resigns - StreetInsider.com (NASDAQ:ATRS)
www.streetinsider.com - August 11 at 3:43 PM
streetinsider.com logoAntares Pharma's (ATRS) CFO Resigns - StreetInsider.com - StreetInsider.com (NASDAQ:ATRS)
www.streetinsider.com - August 11 at 3:43 PM
rttnews.com logoEARNINGS SUMMARY: Details of Antares Pharma Inc. Q2 Earnings Report (NASDAQ:ATRS)
www.rttnews.com - August 9 at 12:29 PM
globenewswire.com logoAntares Pharma Reports Second Quarter 2016 Operating and Financial Results (NASDAQ:ATRS)
globenewswire.com - August 9 at 12:29 PM
sg.finance.yahoo.com logoAntares Pharma reports 2Q loss (NASDAQ:ATRS)
sg.finance.yahoo.com - August 9 at 12:29 PM
tradecalls.org logoAntares Pharma (ATRS) Shares are Up 10% - Trade Calls (NASDAQ:ATRS)
www.tradecalls.org - August 8 at 8:26 AM
twst.com logoAntares Pharma Inc.: Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and Conference Call (NASDAQ:ATRS)
www.twst.com - August 2 at 3:41 PM
finance.yahoo.com logoAntares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and Conference Call (NASDAQ:ATRS)
finance.yahoo.com - August 2 at 8:25 AM
capitalcube.com logoETF’s with exposure to Antares Pharma, Inc. : July 26, 2016 (NASDAQ:ATRS)
www.capitalcube.com - July 26 at 11:44 AM
investornewswire.com logoIs $3 Price Target Attainable For Antares Pharma, Inc. (NASDAQ:ATRS)? - Investor Newswire (NASDAQ:ATRS)
www.investornewswire.com - July 24 at 8:24 AM
News IconAntares Pharma, Inc. (NASDAQ:ATRS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:ATRS)
www.engelwooddaily.com - July 22 at 3:37 PM
News IconEquity Roundup: Stock Performance Focus on Antares Pharma, Inc. (NASDAQ:ATRS) - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 21 at 9:12 PM
News IconAntares Pharma Incorporated (NASDAQ:ATRS) Sellers Covered 57.55% of Their Shorts - Consumer Eagle (NASDAQ:ATRS)
www.consumereagle.com - July 19 at 3:38 PM
News IconBullish Chart Formation for Antares Pharma Inc After Forming Bullish Inverse H&S Pattern - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 18 at 3:41 PM
News IconShares Moving Down on the Week: Antares Pharma Inc. (NASDAQ:ATRS) - Engelwood Daily (NASDAQ:ATRS)
www.engelwooddaily.com - July 17 at 8:21 AM
investornewswire.com logoStrong Sell Calls For Antares Pharma, Inc. (NASDAQ:ATRS) At 0 - Investor Newswire (NASDAQ:ATRS)
www.investornewswire.com - July 17 at 8:21 AM
News IconAntares Pharma Incorporated (NASDAQ:ATRS) Shorted Shares Increased 4.5% After Market Selling - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 16 at 3:36 PM
News IconShares Experiencing a Downtrend: Antares Pharma Inc. (NASDAQ:ATRS) - TGP (NASDAQ:ATRS)
telanaganapress.com - July 15 at 7:56 PM
News IconTrading Performance and Target Watch for Antares Pharma, Inc. (NASDAQ:ATRS) - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 14 at 3:41 PM
News IconInsiders Increasing Positions in: Antares Pharma Inc. (NASDAQ:ATRS) - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 13 at 9:07 PM
news.cmlviz.com logoAntares Pharma Inc. (NasdaqCM:ATRS) Fundamental Star Rating Report - CML News (NASDAQ:ATRS)
news.cmlviz.com - July 13 at 9:07 PM
News IconAntares Pharma, Inc. (NASDAQ:ATRS) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ATRS)
telanaganapress.com - July 13 at 3:40 PM
News IconAntares Pharma Incorporated (NASDAQ:ATRS) Sellers Increased By 4.5% Their Shorts - Consumer Eagle (NASDAQ:ATRS)
www.consumereagle.com - July 13 at 3:40 PM
News IconStock Rating Watch and Earnings Insight for Antares Pharma, Inc. (NASDAQ:ATRS) - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 11 at 8:27 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Antares Pharma, Inc. (ATRS) - Fiscal Standard (NASDAQ:ATRS)
www.fiscalstandard.com - July 11 at 8:27 AM
investornewswire.com logoIs $3 Within Reach For Antares Pharma, Inc. (NASDAQ:ATRS)? - Investor Newswire (NASDAQ:ATRS)
www.investornewswire.com - July 10 at 8:24 AM
News IconAntares Pharma Incorporated (NASDAQ:ATRS) Short Interest Increased By 4.5% - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 10 at 8:24 AM
News IconCan Antares Pharma, Inc. (NASDAQ:ATRS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ATRS)
www.engelwooddaily.com - July 8 at 3:40 PM
News IconCompany Stock Focus for Antares Pharma, Inc. (NASDAQ:ATRS): Which Way Will Shares Head? - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 8 at 3:40 PM
fiscalstandard.com logoBroker Outlook For Antares Pharma, Inc. (ATRS) - Fiscal Standard (NASDAQ:ATRS)
www.fiscalstandard.com - July 7 at 3:40 PM
equities.com logoAntares Pharma Inc. (ATRS) Drops 7.27% on July 05 - Equities.com (NASDAQ:ATRS)
www.equities.com - July 7 at 3:40 PM
News IconShares Dropping Lower in Session: Antares Pharma Inc. (NASDAQ:ATRS) - Telanagana Press (NASDAQ:ATRS)
telanaganapress.com - July 6 at 8:26 AM
News IconAntares Pharma, Inc. (NASDAQ:ATRS) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:ATRS)
telanaganapress.com - July 6 at 8:26 AM
News IconShare Volatility in Focus: Antares Pharma Inc. (NASDAQ:ATRS) - Engelwood Daily (NASDAQ:ATRS)
www.engelwooddaily.com - July 5 at 3:37 PM
News IconShare Performance Recap for: Antares Pharma Inc. (NASDAQ:ATRS) - Press Telegraph (NASDAQ:ATRS)
presstelegraph.com - July 5 at 8:24 AM
fiscalstandard.com logoAntares Pharma, Inc. (ATRS) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:ATRS)
www.fiscalstandard.com - July 4 at 3:37 PM

Social

Antares Pharma (NASDAQ:ATRS) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff